Evidence map›Paper›PMID 35081036›Full record

ArticleJMIR formative research2022

Performance of a Computational Phenotyping Algorithm for Sarcoidosis Using Diagnostic Codes in Electronic Medical Records: Case Validation Study From 2 Veterans Affairs Medical Centers.

Mohamed I Seedahmed, Izabella Mogilnicka, Siyang Zeng, Gang Luo, Mary A Whooley, Charles E McCulloch, Laura Koth, Mehrdad Arjomandi

Open access · goldAbstract read
In one paragraph

Article in JMIR formative research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 citations in OpenAlex.

  1. Sarcoidosis in hospitalised patients in Western Australia: A long-term study on prevalence, comorbidity and mortality.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Big data in sarcoidosis.Current opinion in pulmonary medicine · 2024
    Review
  6. Epidemiology of Sarcoidosis in U.S. Veterans from 2003 to 2019.Annals of the American Thoracic Society · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Mohamed I SeedahmedDivision of Pulmonary, Critical Care, Allergy and Immunology, and Sleep, Department of Medicine, University of California San Francisco, San Francisco, CA, United States.ORCID https://orcid.org/0000-0002-7446-7346
Izabella MogilnickaSan Francisco Veterans Affairs Medical Center, San Francisco, CA, United States.ORCID https://orcid.org/0000-0002-5735-8375
Siyang ZengSan Francisco Veterans Affairs Medical Center, San Francisco, CA, United States.ORCID https://orcid.org/0000-0001-9346-301X
Gang LuoDepartment of Biomedical Informatics and Medical Education, School of Medicine, University of Washington, Seattle, WA, United States.ORCID https://orcid.org/0000-0001-7217-4008
Mary A WhooleySan Francisco Veterans Affairs Medical Center, San Francisco, CA, United States.ORCID https://orcid.org/0000-0002-5943-0078
Charles E McCullochDepartment of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA, United States.ORCID https://orcid.org/0000-0002-1279-6179
Laura Koth *Division of Pulmonary, Critical Care, Allergy and Immunology, and Sleep, Department of Medicine, University of California San Francisco, San Francisco, CA, United States.ORCID https://orcid.org/0000-0001-9541-3622
Mehrdad Arjomandi *Division of Pulmonary, Critical Care, Allergy and Immunology, and Sleep, Department of Medicine, University of California San Francisco, San Francisco, CA, United States.ORCID https://orcid.org/0000-0002-0116-9217
San Francisco VA Medical Center · USUniversity of California, San Francisco · USUniversity of Washington · US

Funding

University of Washington Biomedical Informatics and Data Science Research Training ProgramT15LM007442 · NLM · UNIVERSITY OF WASHINGTON · PI JOHN H. GENNARI, Andrea L. Hartzler · 2002 to 2026
$19.6M
NRSA Training CoreTL1TR001871 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KANAYA, ALKA M., SOMSOUK, MA · 2016 to 2025
$10.1M
The Impact of Environmental Exposures on Sarcoidosis Incidence and MortalityR01HL157533 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Wonder P. Drake, Connie C. W. Hsia · 2022 to 2026
$5.7M
NCATS NIH HHS TL1 TR001871NHLBI NIH HHS R01 HL157533NLM NIH HHS T15 LM007442
6 · The paper itself

Abstract

backgroundElectronic medical records (EMRs) offer the promise of computationally identifying sarcoidosis cases. However, the accuracy of identifying these cases in the EMR is unknown.

objectiveThe aim of this study is to determine the statistical performance of using the International Classification of Diseases (ICD) diagnostic codes to identify patients with sarcoidosis in the EMR.

methodsWe used the ICD diagnostic codes to identify sarcoidosis cases by searching the EMRs of the San Francisco and Palo Alto Veterans Affairs medical centers and randomly selecting 200 patients. To improve the diagnostic accuracy of the computational algorithm in cases where histopathological data are unavailable, we developed an index of suspicion to identify cases with a high index of suspicion for sarcoidosis (confirmed and probable) based on clinical and radiographic features alone using the American Thoracic Society practice guideline. Through medical record review, we determined the positive predictive value (PPV) of diagnosing sarcoidosis by two computational methods: using ICD codes alone and using ICD codes plus the high index of suspicion.

resultsAmong the 200 patients, 158 (79%) had a high index of suspicion for sarcoidosis. Of these 158 patients, 142 (89.9%) had documentation of nonnecrotizing granuloma, confirming biopsy-proven sarcoidosis. The PPV of using ICD codes alone was 79% (95% CI 78.6%-80.5%) for identifying sarcoidosis cases and 71% (95% CI 64.7%-77.3%) for identifying histopathologically confirmed sarcoidosis in the EMRs. The inclusion of the generated high index of suspicion to identify confirmed sarcoidosis cases increased the PPV significantly to 100% (95% CI 96.5%-100%). Histopathology documentation alone was 90% sensitive compared with high index of suspicion.

conclusionsICD codes are reasonable classifiers for identifying sarcoidosis cases within EMRs with a PPV of 79%. Using a computational algorithm to capture index of suspicion data elements could significantly improve the case-identification accuracy.

Indexed as

computational phenotypediagnostic codeselectronic medical recordsEMRspractice guidelinessarcoidosisVAVeterans Affairs

Identifiers

PMID35081036
PMCPMC8928044
OpenAlexW4210400325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.